Flebogamma Injection, Solution
Product Images NDC 61953-0004

This is a description of an Immune Globulin Intravenous medication named Flebogamma® 5% DI. The medicine has a National Drug Code of 61953-0004-6 and contains 0.5g of active ingredient in a 10mL solution. The medication is only available with a prescription and must be stored at temperatures between 2-25 °C. The manufacturer of the medication is Instituto Grifols, SA, located in Barcelona, Spain. There is a lot number and expiry date included in the information.*

The text seems to be a product description for immune globulin intravenous (human) called Flebogamma. It provides information about dosage, administration, packaging, and the manufacturing company, Grifols S.A. However, the text contains many errors and some of the words are not decipherable, making the description incomplete and difficult to understand.*

This is a description of Immune Globulin Intravenous (Human) medication called Flebogamma® 5% DIF. It contains 20 g in 400 mL Ruonb. m, and each 400 L contains Immune Glbulin (unar) 205 Desobitol 20 g rotein ontts 50 gL. The dosage and injections are specified in the package, and it should not be used if turbid. The patient and physician should discuss the risks and benefits of this product. The manufacturer is Instituto Gifls, located in Barcelona, Spain, with License no. 18. There are also lot numbers and expiration dates on the packaging.*

This is a description of Hebogamma 5% DIF, an immune globulin administered intravenously. It comes in a 2.5g dose contained within a 50mL container and requires a prescription to purchase. It is manufactured by Instituto Rifols in Barcelona, Spain, and has a US license number of 1181. Dosage and administration instructions can be found in the package insert, and it should be stored between 2-25°C (36-77°F) and used promptly once the container is opened. The text also includes several lot numbers and an NDC code for identification purposes.*

This text appears to be a description of a medical product named "Immune Globulin Intravenous (Human)" manufactured by "Instituto Grifols, S.A". It is a solution for infusion that comes in a 10 mL vial and is used for intravenous administration. It contains 0.5g of immune globulin, and its dosage and administration should only be done as per the instructions of a physician. The product should not be used if turbid and should be stored at a specific temperature range. The package insert should be consulted for more information, and any unused contents and administration devices must be discarded properly.*

This is a description of a medication called "Flebogamma® 5% DIF" which is an intravenous immune globulin solution used for fusion. The medication comes in a 25g/50mL solution. There is a caution for the physician and the patient to discuss the medication's precautions. There are also instructions for the proper handling of the medication and administration devices. The medication is manufactured by Grifols. The text includes various identification codes such as NDC 61953 00042 and NOC 6195300042.*

This is a description of Flebogamma® 5% DIF, an intravenous immunoglobulin used to treat certain immune deficiencies. The text includes instructions for use and storage temperature information. The product is manufactured by Grifols.*

This is a description of a product offered by Grifols, which is Immune Globulin Intravenous (Human) with the brand name Hebogamma®. It comes in a 10g/200ml package and may have uses in improving immunity.*

This is a description of a medical product called Immune Globulin Intravenous (Human), with the brand name Flebogamma® 5% DIF. The packaging contains a solution of 5g in 100mL, and it is only for intravenous use. The package insert includes information on dosage and administration. The product should be stored between 2-25 °C (36-77 °F) and should not be used if the solution is turbid. This product is manufactured by Instituto Grifol in Barcelona, Spain, and is licensed in the US under License No. 1181. The package also includes lot information and expiration dates. However, the first line of text is not readable and therefore, not included in the description.*